Determination of picogram levels of midazolam, and 1- and 4-hydroxymidazolam in human plasma by gas chromatography-negative chemical ionization-mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 802, Issue 2, 2004, Pages 339-345

  Eap, C B ^a   Bouchoux, G ^b   Golay, K Powell ^a   Baumann, P ^a  

^a Hopital de Cery   (Switzerland)

^b LABORATOIRE HÉTÉROÉLÉMENTS ET COORDINATION   (France)

Author keywords

Hydroxymidazolam; Midazolam

Indexed keywords

BIOLOGICAL MATERIALS; BIOMEDICAL ENGINEERING; CALIBRATION; IONIZATION; MASS SPECTROMETRY;

CYTOCHROMES;

GAS CHROMATOGRAPHY;

1 HYDROXYMIDAZOLAM; 4 HYDROXYMIDAZOLAM; ETHYLENE; MIDAZOLAM; N ETHYLOXAZEPAM; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALIBRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DERIVATIZATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; GAS CHROMATOGRAPHY; HUMAN; IONIZATION; MASS SPECTROMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STANDARD;

EID: 1342264274     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2003.12.014     Document Type: Article

References (17)

1. S.A. Wrighton, K.E. Thummel, in: R.H. Levy, K.E. Thummel, W.F. Trager, P.D. Hansten, M. Eichelbaum (Eds.), Metabolic Drug Interactions, Lippincott Williams & Wilkins, Philadelphia, USA, 2000, p. 115 (Chapter 10).
2. Watkins P.B. Pharmacogenetics. 4:1994;171.
3. Streetman D.S., Bertino J.S. Jr., Nafziger A.N. Pharmacogenetics. 10:2000;187.
4. Heizmann P., Eckert M., Ziegler W.H. Brit. J. Clin. Pharmacol. 16:1983;43S.
5. Backman J.T., Olkkola K.T., Neuvonen P.J. Clin. Pharmacol. Therapeut. 59:1996;7.
6. de Wildt S.N., Kearns G.L., Hop W.C., Murry D.J., Abdel-Rahman S.M., van den Anker J.N. Clin. Pharmacol. Therapeut. 70:2001;525.
7. Martens J., Banditt P. J. Chromatogr. B. 692:1997;95.
8. Thummel K.E., Shen D.D., Podoll T.D., Kunze K.L., Trager W.F., Hartwell P.S., Raisys V.A., Marsh C.L., McVicar J.P., Barr D.M., Perkins J.D., Carithers R.L. Jr. J. Pharmacol. Exp. Therapeut. 271:1994;549.
9. Paine M.F., Shen D.D., Kunze K.L., Perkins J.D., Marsh C.L., McVicar J.P., Barr D.M., Gillies B.S., Thummel K.E. Clin. Pharmacol. Therapeut. 60:1996;14.
10. Reed M.D., Rodarte A., Blumer J.L., Khoo K.C., Akbari B., Pou S., Kearns G.L. J. Clin. Pharmacol. 41:2001;1359.
11. Zhu B., Ou-Yang D.S., Cheng Z.N., Huang S.L., Zhou H.H. Acta Pharmacol. Sin. 22:2001;634.
12. Carrillo J.A., Ramos S.I., Agúndez J.A.G., Martinez C., Benitez J. Therapeut. Drug Monitor. 20:1998;319.
13. Marquet P., Baudin O., Gaulier J.M., Lacassie E., Dupuy J.L., Francois B., Lachâtre G. J. Chromatogr. B. 734:1999;137.
14. Kashuba A.D.M., Bertino J.S., Rocci M.L., Kulawy R.W., Beck D.J., Nafziger A.N. Clin. Pharmacol. Therapeut. 64:1998;269.
15. McCrea J., Prueksaritanont T., Gertz B.J., Carides A., Gillen L., Antonello S., Brucker M.J., Miller-Stein C., Osborne B., Waldman S. J. Clin. Pharmacol. 39:1999;1212.
16. Thummel K.E., Shen D.D., Podoll T.D., Kunze K.L., Trager W.F., Bacchi C.E., Marsh C.L., Vicar J.P., Barr C.L., Perkins J.D. J. Pharmacol. Exp. Therapeut. 271:1994;557.
17. Villeneuve J.P., Ecuyer L.L., De Maeght S., Bannon P. Clin. Pharmacol. Therapeut. 67:2000;242.